Skip to main content
Quest Diagnostics
Click here to learn more from our experts
Call
Menu

We’re proud to bring digital cytology and FDA-cleared AI into our cervical cancer screening process. 

As part of our commitment to leveraging the latest innovative technologies & providing insights that inspire action, we’re introducing the HologicTM GeniusTM Digital Diagnostics System to enhance cervical cancer screening.

Innovative technology at work

The Hologic Genius Digital Diagnostics system screens for cervical cancer by using an artifical intelligence algorithm and high-definition monitor to help identify precancerous and cancer cells.

AI-powered screening efficiency

By combining AI with human expertise, we’re increasing screening efficiency and disease detection.

 

 

Identification of precancerous and cancerous cells

This platform uses AI to assist with the identification of precancerous and cancerous cells, enhancing the way our teams screen at the cellular level.

 

 

 

The Hologic Genius Digital Diagnostics system is the first and only FDA-cleared groundbreaking digital cytology platform to screen for cervical cancer.

At the forefront of innovation

This integration marks a big step forward in how we approach diagnostic accuracy and efficiency in cervical cancer screening.

- Anthony R. Henderson, National Laboratory Operations Director for Cytology, Quest Diagnostics
A Clifton Lab employee reviewing samples from Genius technology

Interested to learn more about digital cytology?

 

Fill out the form below and a Quest representative will be in touch to discuss.

857

* indicates required

Our company

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.